Medication-Assisted Treatment for Opioid-Use Disorder

Author/s: 
Oesterle, TS, Thusius, NJ, Rummans, TA, Gold, MS
Date Added: 
October 3, 2019
Journal/Publication: 
Mayo Clinic Proceedings
Publisher: 
Mayo Foundation for Medical Education and Research / Elsevier Inc.
Publication Date: 
September 9, 2019
Issue: 
10
Volume: 
94
Pages: 
2072-2086
Type: 
Meta-analyses, Reviews, and Guidelines
Format: 
Article
DOI (1): 
10.1016/j.mayocp.2019.03.029
PMID (1): 
31543255

RPR Commentary

A nice review of how and when to use the three available medications for treating patients with opioid dependency.  James W. Mold, MD, MPH

Abstract

The United States is in the midst of a national opioid epidemic. Physicians are encouraged both to prevent and treat opioid-use disorders (OUDs). Although there are 3 Food and Drug Administration-approved medications to treat OUD (methadone, buprenorphine, and naltrexone) and there is ample evidence of their efficacy, they are not used as often as they should. We provide a brief review of the 3 primary medications used in the treatment of OUD. Using data from available medical literature, we synthesize existing knowledge and provide a framework for how to determine the optimal approach for outpatient management of OUD with medication-assisted treatments.

Text Availability

Free full text